Table 1.
Correlation of MARCH1 expression with clinicopathological characteristics in 20 CRC patients
| Patients | Expression of MARCH1 | ||||
|---|---|---|---|---|---|
| (n = 20) | Low | High | r | p | |
| Gender | |||||
| Male | 12 | 5 | 7 | .042 | .862 |
| Female | 8 | 3 | 5 | ||
| Age (years) | |||||
| <60 | 3 | 2 | 1 | .229 | .332 |
| ≥60 | 17 | 6 | 11 | ||
| Tumor diameter (cm) | |||||
| <4 | 7 | 2 | 5 | −.171 | .471 |
| ≥4 | 13 | 7 | 7 | ||
| Tumor site | |||||
| Colon | 8 | 3 | 5 | −.042 | .862 |
| Rectum | 12 | 5 | 7 | ||
| Differentiation | |||||
| Low | 1 | 0 | 1 | .187 | .429 |
| Medium‐high | 19 | 8 | 11 | ||
| Infiltration depth | |||||
| Mucosa and submucosa | 2 | 0 | 2 | −.047 | .845 |
| Muscularis propria | 3 | 2 | 1 | ||
| Adventitia | 15 | 6 | 9 | ||
| Lymph node metastasis | |||||
| Negative | 17 | 7 | 10 | .057 | .811 |
| Positive | 3 | 1 | 2 | ||
| T stage | |||||
| T1–T2 | 5 | 2 | 3 | .000 | 1.000 |
| T3–T4 | 15 | 6 | 9 | ||
| N stage | |||||
| N0 | 17 | 7 | 10 | .057 | .811 |
| N1–N2 | 3 | 1 | 2 | ||
| M stage | |||||
| M0 | 19 | 8 | 11 | 0.187 | .429 |
| M1 | 1 | 1 | 0 | ||
| AJCC stage | |||||
| I–II | 18 | 7 | 11 | −.068 | .776 |
| III–IV | 2 | 1 | 1 | ||